We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBWI icon
326
Bath & Body Works
BBWI
$4.13B
$4.93M 0.06%
221,083
-121,818
-36% -$2.68M
PNC icon
327
PNC Financial Services
PNC
$99.6B
$4.9M 0.06%
39,980
+2,352
+6% +$291K
CME icon
328
CME Group
CME
$91.8B
$4.89M 0.06%
29,740
+739
+3% +$131K
ATO icon
329
Atmos Energy
ATO
$29.7B
$4.88M 0.06%
34,384
+2,091
+6% +$204K
HPQ icon
330
HP
HPQ
$24.3B
$4.86M 0.06%
199,252
-11,560
-5% -$245K
VAR
331
DELISTED
Varian Medical Systems, Inc.
VAR
$4.86M 0.06%
34,258
+22,814
+199% +$3M
CXO
332
DELISTED
CONCHO RESOURCES INC.
CXO
$4.81M 0.06%
43,324
-31,334
-42% -$3.54M
ANSS
333
DELISTED
Ansys
ANSS
$4.8M 0.06%
26,265
+19,131
+268% +$3.24M
TTWO icon
334
Take-Two Interactive
TTWO
$45.3B
$4.8M 0.06%
50,847
+44,624
+717% +$4.33M
FTNT icon
335
Fortinet
FTNT
$112B
$4.8M 0.06%
+285,700
New +$4.55M
MLM icon
336
Martin Marietta Materials
MLM
$34.3B
$4.78M 0.06%
23,762
-8,940
-27% -$1.67M
PVH icon
337
PVH
PVH
$3.87B
$4.78M 0.06%
39,188
+1,660
+4% +$182K
DERM
338
DELISTED
Dermira, Inc.
DERM
$4.74M 0.06%
+350,000
New +$2.92M
MAS icon
339
Masco
MAS
$16.4B
$4.72M 0.06%
90,040
-39,495
-30% -$1.41M
MRT
340
DELISTED
MedEquities Realty Trust, Inc.
MRT
$4.71M 0.06%
+422,814
New +$4.58M
WRK
341
DELISTED
WestRock Company
WRK
$4.68M 0.06%
121,972
+16,753
+16% +$655K
HST icon
342
Host Hotels & Resorts
HST
$17.1B
$4.62M 0.06%
190,644
+28,465
+18% +$525K
BN icon
343
Brookfield
BN
$103B
$4.55M 0.06%
273,712
-125,694
-31% -$1.96M
SRE icon
344
Sempra
SRE
$59.7B
$4.53M 0.06%
71,990
+1,086
+2% +$64K
GM icon
345
General Motors
GM
$78.7B
$4.52M 0.06%
121,917
-105,105
-46% -$3.99M
EW icon
346
Edwards Lifesciences
EW
$47.8B
$4.52M 0.06%
70,809
– –
TM icon
347
Toyota
TM
$216B
$4.49M 0.06%
38
+1
+3% +$121
BBY icon
348
Best Buy
BBY
$18.6B
$4.47M 0.06%
51,982
+20,546
+65% +$1.28M
HES
349
DELISTED
Hess
HES
$4.38M 0.06%
72,733
-150,617
-67% -$8.29M
MYGN icon
350
Myriad Genetics
MYGN
$515M
$4.37M 0.06%
+131,732
New +$4.01M
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.